Thomas Moumneh

Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism

Benjamin Planquette, Laurent Bertoletti, Anaïs Charles‐Nelson et al. · CHEST Journal · 2021 · 142 citations

Thrombosis, Venous Thrombosis, Rivaroxaban Vs Dalteparin +10

Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial

Pierre‐Marie Roy, Andréa Penaloza, Olivier Hügli et al. · European Heart Journal · 2021 · 139 citations · Full text

Pulmonary embolism rule-out criteria (PERC) rule in European patients with low implicit clinical probability (PERCEPIC): a multicentre, prospective, observational study

Andréa Penaloza, Caroline Soulié, Thomas Moumneh et al. · The Lancet Haematology · 2017 · 92 citations

Thrombosis, Pulmonary Embolism, Venous Thrombosis +11

Net clinical benefit of hospitalization versus outpatient management of patients with acute pulmonary embolism

P.M. Roy, Daniel J. Corsi, Marc Carrier et al. · Journal of Thrombosis and Haemostasis · 2017 · 55 citations · Full text

Net Clinical Benefit, Clinical Management, Pulmonary Embolism +8

Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: A cohort study

Thomas Moumneh, Jérémie Riou, Delphine Douillet et al. · Journal of Thrombosis and Haemostasis · 2020 · 51 citations · Full text

Thrombosis, Pulmonary Embolism, Venous Thrombosis +12